Sheng‐Liang Cheng

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

China Medical University(Current)

National Tsing Hua University

Sheng‐Liang Cheng is an author at China Medical University specializing in programmed cell death protein 1 regulation, sting pathway, and nanoparticle drug delivery.

Publications per year

2024–2025

Publications

Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy

Sheng‐Liang Cheng, H.T. Lee, Chung‐Pin Li et al. · ACS Nano · 2024 · 50 citations · Full text

Pharmacy, Bioengineering, Immunology +17

CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma

Sheng‐Liang Cheng, Chien-Huang Wu, Yun‐Jen Tsai et al. · Journal of Controlled Release · 2025 · 18 citations

Medicine, Cancer Biology, Oncology +17

1–2 of 2